Underwriters fully exercise greenshoe for 500,000 more shares
By Susanna Moon
Chicago, July 14 – Anthera Pharmaceuticals, Inc. said underwriters fully exercised the over-allotment option to purchase another 500,000 common shares, bringing the public offering of common stock to $28.75 million.
As previously announced, the company priced the $25 million public sale of stock on July 13 with a $3.75 million 30-day greenshoe.
The company sold 3,833,334 shares at a price of $7.50 per share, which includes the greenshoe exercise.
The price per share was a 9.91% discount to the closing share price of $8.325 on July 10.
Citigroup Global Markets Inc. and Piper Jaffray & Co. are the joint bookrunning managers.
Proceeds will be used for clinical research and development and general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $28.75 million (including greenshoe for $3.75 million)
|
| Shares: | 3,833,334
|
| Price: | $7.50
|
| Warrants: | No
|
| Joint bookrunners: | Citigroup Global Markets Inc. and Piper Jaffray & Co.
|
| Co-manager: | SunTrust Robinson Humphrey, Inc.
|
| Announcement date: | July 8
|
| Pricing date: | July 13
|
| Settlement date: | July 14
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $8.325 at close July 10
|
| Market capitalization: | $292.26 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
